Eczema (Atopic Dermatitis)
Eczema (Atopic Dermatitis)
MEDI-MM36-301 Enrolling

Atopic Dermatitis – Research Trial (10 Weeks)

Treatment: Topical Age: 2 Years and Older

Children, adolescents, and adults aged 2 years or older with a diagnosis of atopic dermatitis which has persisted for more than 6 months are needed for this clinical research trial.  Eligible participants must have mild to moderate disease and no active or acute skin infections.

Participants will receive investigational topical treatment (active study drug) or placebo (inactive substance), via a cream.  Study treatment and study-related assessments will be provided at no cost.  Reimbursement for study-related expenses will be provided.

Study participation will last about 10 weeks and involve about 7 visits to the study centre.



Participating Locations

United States

Participating Experts

Dr. Matthew Zirwas


You May Also Be Interested In

Similar Trials

No Similar Trials Found

The following information is from

Last Update Posted: February 01, 2023

Study Description

  • Condition or Disease:

    Atopic Dermatitis (Eczema)

  • Ages Eligible for Study:

    2 Years and Older

  • Sexes Eligible for Study:

    Male and Female

Terms and Conditions –
Purpose of Database. The U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine, has developed to provide patients, family members, and members of the public current information about clinical research studies.


Learn More About

Eczema (Atopic Dermatitis)

Learn More
2022 all rights reserved probity medical research inc
find a trial
filter trials
Skip to content